
zzso zzso 2A is a novel potential therapeutic target in several types of chronic and acute zzso and its zzso is a common event in acute zzso zzso zzso of zzso is essential to inhibit protein zzso 2A in chronic zzso zzso but its importance in acute zzso leukemia has not yet been zzso 

We zzso zzso expression by real time reverse zzso zzso chain reaction in 214 acute zzso leukemia patients at zzso Western zzso was performed in acute zzso leukemia cell lines and in 16 patients' zzso We studied the effect of zzso using cell viability zzso zzso analysis of the zzso promoter, zzso zzso and zzso zzso were performed to evaluate the zzso regulation of zzso 

zzso zzso was found in zzso patients, for a prevalence of zzso Patients with zzso zzso had worse overall survival ( zzso and zzso survival ( zzso zzso of zzso was confirmed by western zzso in both cell lines and patients' zzso zzso analysis showed that zzso promotes zzso and restores cell viability after protein zzso 2A zzso We identified zzso zzso as a mechanism involved in zzso deregulation in acute zzso leukemia zzso 

These findings suggest that zzso zzso is a key mechanism in the zzso of zzso in acute zzso zzso and that zzso zzso contributes to the deregulation of zzso Furthermore, zzso zzso is associated with a poor outcome in acute zzso zzso and it can be used to identify a zzso of patients who could benefit from future treatments based on zzso zzso 

